CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinomaPadmanee Sharma, Eiichi Sato, Dean F. Bajorin et al.|Proceedings of the National Academy of Sciences|2007Cited by 517
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancerEmily J. Faivre, Yu Shen, Keith F. McDaniel et al.|Nature|2020Cited by 404
The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents <i>In Vitro</i> and <i>In Vivo</i>Jun Chen, Steven W. Elmore, Sha Jin et al.|Molecular Cancer Therapeutics|2011Cited by 149